It relays the molecular crosstalk to mediate the development of hallmarks of cancer, directly via its target genes such as IGF2, CD18, VEGF, FN1, GLUT1 and BCL2 and indirectly by inducing other factors such as insulin, leptin and negatively regulating PTEN. This evidence concerns the gene LEP and cancer.